ADH7 and esophageal squamous cell carcinoma: Additionally, ADH7 rs17028973 TT carriers showed a 2.62-fold increased ESCC risk compared with those carrying the CC genotype in the validation set (95%CI = 1.75–3.93, P<0.001) (Table 3).